Accendra Health Announces Third Quarter 2026 Earnings Release Date and Conference CallBusiness Wire • 10/22/26
Accendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing StandardBusiness Wire • 10/09/26
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of GrowthBusiness Wire • 09/17/26
Accendra Health Updates on Capital Allocation and CEO Succession Timing PlansBusiness Wire • 08/17/26
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder ValueBusiness Wire • 08/10/26
Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor SearchBusiness Wire • 08/10/26
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference CallBusiness Wire • 07/27/26
Is the Options Market Predicting a Spike in Accendra Health Stock?Zacks Investment Research • 07/02/26
Accendra Health Announces Expiration and Final Results of Offers and Consent SolicitationsBusiness Wire • 06/24/26
Accendra Health, Inc. (ACH) Shareholder/Analyst Call Prepared Remarks TranscriptSeeking Alpha • 05/14/26
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization TransactionBusiness Wire • 05/11/26
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference CallBusiness Wire • 05/01/26
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference CallBusiness Wire • 02/05/26